News
Article of the week: Phase 1b study of isatuximab plus lenalidomide and dexamethasone
A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma'Â is a study intended to assess the...
Article of the week: The role of serum IgM levels as a predictor of symptomatic hyperviscosity in Waldenström’s macroglobulinaemia (WM)
This week's Article of the Week is a study that was recently published in the British Journal of Haematology on the role of serum IgM levels as a...
Drugs for incurable blood cancer ‘should be available’
About 400 New Zealanders a year are diagnosed with the blood cancer multiple myeloma, and the number is rising. A malignancy of the plasma cell, it...
Article of the week: Monoclonal antibody therapy in multiple myeloma
This review discusses pre-clinical and clinical studies on the use of monoclonal antibodies in multiple myeloma, including agents which have been...
Launch
On November 22, Â 2016 Â in Wellington a group of New Zealand based hematology specialists led by Kenneth Romeril launched a new initiative for...